All our products are certified to EU Good Manufacturing Practice (GMP) which is the highest standard that a producer must meet in order to place a medicinal product on the European market. The complete process is EU-GMP certified, from the supply of dried cannabis flower to the processing and packaging of our finished products. This guarantees that our products consistently meet quality, safety and efficacy attributes throughout their shelf-life.

This high level of quality and standardization enables prescribers and patients to achieve the desired therapeutic effect with minimal levels of potential side effects. It also enables numerous researchers in the field to achieve more robust clinical data through evidence-based methods.

Activities related to the production of cannabis for medicinal and research purposes are regulated by the Malta Medicines Authority through comprehensive evaluation of scientific and technical documentation, security considerations, and EU Good Manufacturing Practice (GMP).

Alphafarma’s production facility in Malta has undergone such a thorough review process, leading to the attainment of EU-GMP certification, ensuring that all products are consistently formulated and processed to the highest standards of quality, safety and efficacy.